Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study (NCT05712161)

🧪 Interventions in This Study

• DurAVRTM THV System (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (5 Sites)

• Tucson Medical Center — Tucson, Arizona
• University of Michigan — Ann Arbor, Michigan
• Columbia University Medical Center/NYPH — New York, New York
• Montefiore Medical Center — The Bronx, New York
• Cleveland Clinic Foundation — Cleveland, Ohio

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Aortic Stenosis

• PERIGON Pivotal Trial — Los Angeles, California
• ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement — Birmingham, Alabama
• PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis — Birmingham, Alabama
• Application of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study) — Edmonton, Alberta
• Systematic Ambulatory ECG Monitoring Following TAVI — Québec, Quebec

Explore by condition: All Aortic Stenosis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.